Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
4.450
+0.470 (11.81%)
Feb 5, 2025, 10:53 AM EST - Market open

Aprea Therapeutics Revenue

Aprea Therapeutics had revenue of $354.62K in the quarter ending September 30, 2024, with 11.00% growth. This brings the company's revenue in the last twelve months to $1.31M, up 130.31% year-over-year. In the year 2023, Aprea Therapeutics had annual revenue of $583.23K.

Revenue (ttm)
$1.31M
Revenue Growth
+130.31%
P/S Ratio
14.74
Revenue / Employee
$187,263
Employees
7
Market Cap
24.19M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023583.23K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.